The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrade, R. M.
Right arrow Articles by Subauste, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrade, R. M.
Right arrow Articles by Subauste, C. S.
The Journal of Immunology, 2003, 171: 6750-6756.
Copyright © 2003 by The American Association of Immunologists

CD154 Activates Macrophage Antimicrobial Activity in the Absence of IFN-{gamma} through a TNF-{alpha}-Dependent Mechanism 1

Rosa M. Andrade, Matthew Wessendarp and Carlos S. Subauste2

Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267

Protection against certain intracellular pathogens can take place in the absence of IFN-{gamma} through mechanisms dependent on TNF-{alpha}. In this regard, patients with partial defect in IFN-{gamma} receptor 1 are not susceptible to toxoplasmosis. Thus, we used a model of Toxoplasma gondii infection to investigate whether CD154 modulates IFN-{gamma}-independent mechanisms of host protection. Human monocyte-derived macrophages treated with recombinant CD154 exhibited increased anti-T. gondii activity. The number of tachyzoites per 100 macrophages at 20 h postinfection was lower in CD154-treated macrophages compared with controls. This was accompanied by a decrease in the percentage of infected cells in CD154-treated macrophages at 20 h compared with 1 h postinfection. CD154-bearing cells also induced antimicrobial activity in T. gondii-infected macrophages. CD154 enhanced macrophage anti-T. gondii activity independently of IFN-{gamma}. TNF-{alpha} mediated the effects of CD154 on macrophage anti-T. gondii activity. CD154 increased TNF-{alpha} production by T. gondii-infected macrophages, and neutralization of TNF-{alpha} inhibited the effect of CD154 on macrophage anti-T. gondii activity. These results demonstrate that CD154 triggers TNF-{alpha}-dependent antimicrobial activity in macrophages and suggest that CD154 regulates the mechanisms of host protection that take place when IFN-{gamma} signaling is deficient.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
C. S. Subauste and M. Wessendarp
CD40 Restrains In Vivo Growth of Toxoplasma gondii Independently of Gamma Interferon
Infect. Immun., March 1, 2006; 74(3): 1573 - 1579.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Danese, M. Sans, F. Scaldaferri, A. Sgambato, S. Rutella, A. Cittadini, J. M. Pique, J. Panes, J. A. Katz, A. Gasbarrini, et al.
TNF-{alpha} Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn's Disease
J. Immunol., February 15, 2006; 176(4): 2617 - 2624.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Andrade, M. Wessendarp, J.-A. C. Portillo, J.-Q. Yang, F. J. Gomez, J. E. Durbin, G. A. Bishop, and C. S. Subauste
TNF Receptor-Associated Factor 6-Dependent CD40 Signaling Primes Macrophages to Acquire Antimicrobial Activity in Response to TNF-{alpha}
J. Immunol., November 1, 2005; 175(9): 6014 - 6021.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. M. Andrade, J.-A. C. Portillo, M. Wessendarp, and C. S. Subauste
CD40 Signaling in Macrophages Induces Activity against an Intracellular Pathogen Independently of Gamma Interferon and Reactive Nitrogen Intermediates
Infect. Immun., May 1, 2005; 73(5): 3115 - 3123.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.